NCT02129920 RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke Status UNKNOWN Phase N/A
NCT02129842 Is Endothelial Function a Predictor of Successful Ablation Therapy Provided to Patients With Atrial Fibrillation? Status COMPLETED Phase N/A
NCT02126982 Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence Status COMPLETED Phase N/A
NCT02120560 Anticoagulation in AF Ablation and Effects on Neurocognitive Function Status WITHDRAWN Phase PHASE4
NCT02107027 Pulmonary Veins Circular Ablation Catheter Evaluation for Atrial Fibrillation Status UNKNOWN Phase NA
NCT02105584 Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT02101541 FIRM as a Stand-alone Procedure in the Treatment of Atrial Fibrillation Status COMPLETED Phase NA
NCT02100228 Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) Status COMPLETED Phase PHASE4
NCT02099331 Cardiac Surgery and the Risk of Atrial Fibrillation: an Intervention Trial Evaluating Melatonin Status WITHDRAWN Phase PHASE2
NCT02093949 Substrate Ablation Guided by High Density Mapping in Atrial Fibrillation Status COMPLETED Phase N/A
NCT02090075 Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque Status COMPLETED Phase PHASE4
NCT02082548 Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT02081807 Sequential Expansion of Comparative Effectiveness of Anticoagulants Status COMPLETED Phase N/A